Breaking News Instant updates and real-time market news.

KNSA

Kiniksa

$13.98 /

-0.02 (-0.14%)

09:52
01/13/20
01/13
09:52
01/13/20
09:52

Kiniksa reiterates 2020 clinical data readouts

Kiniksa Pharmaceuticals announced recent pipeline progress and upcoming 2020 clinical milestones. Sanj K. Patel, Chief Executive Officer and Chairman of the Board of Kiniksa will provide further detail in a corporate presentation at the 38th Annual J.P. Morgan Healthcare Conference today, Monday, January 13, 2020 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco, California. Recent Pipeline Progress and Expected 2020 Clinical Data Readouts: Rilonacept: Kiniksa has achieved its enrollment target for RHAPSODY, a global, randomized-withdrawal design, pivotal Phase 3 trial of rilonacept in patients with recurrent pericarditis. The company expects top-line data in the second half of 2020. Kiniksa recently announced the U.S. Food and Drug Administration granted Breakthrough Therapy designation for rilonacept for the treatment of recurrent pericarditis. Kiniksa's Breakthrough Therapy application was based on final data from an open-label Phase 2 clinical trial of rilonacept in a range of recurrent pericarditis populations. Mavrilimumab: Kiniksa has achieved its enrollment target for a global Phase 2 proof-of-concept trial of mavrilimumab in patients with giant cell arteritis. The company expects top-line data in the second half of 2020. Kiniksa and Kite, a Gilead company, recently announced a clinical collaboration evaluating the investigational combination of Yescarta and mavrilimumab in relapsed or refractory large B-cell lymphoma. The objective of the study is to determine the effect of mavrilimumab on the safety of Yescarta. Preclinical evidence shows the potential for interruption of granulocyte macrophage colony stimulating factor signaling to disrupt chimeric antigen receptor T cell-mediated inflammation without disrupting anti-tumor efficacy. KPL-716: Kiniksa expects top-line data from a Phase 2a clinical trial of KPL-716 in patients with prurigo nodularis in the first half of 2020. Kiniksa expects interim data from cohorts of a Phase 2 clinical trial of KPL-716 in diseases characterized by chronic pruritus in the first half of 2020. KPL-404: Kiniksa is enrolling and dosing subjects in a single-ascending-dose Phase 1 clinical trial of KPL-404 in healthy volunteers. The first-in-human trial will provide safety data and pharmacokinetics as well as receptor occupancy and T-cell Dependent Antibody Response. Top-line data are expected in the second half of 2020. KPL-045: Based on preclinical data in the context of Kiniksa's portfolio, the company no longer plans to progress KPL-045 into clinical development.

KNSA Kiniksa
$13.98 /

-0.02 (-0.14%)

03/11/19 LEHM
Kiniksa initiated with an Overweight at Barclays
08/14/19 JMPS
Kiniksa price target lowered to $35 from $44 at JMP Securities
12/06/19 GSCO
Kiniksa assumed to Buy from Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

Syndicate
New Frontier Health files to sell 127.34M ordinary shares for holders » 17:10
01/24/20
01/24
17:10
01/24/20
17:10
NFH

New Frontier Health

$9.45 /

+0.105 (+1.12%)

Also files to sell 12.5M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Syndicate
New Frontier Health files to sell 26.875M ordinary shares  17:09
01/24/20
01/24
17:09
01/24/20
17:09
NFH

New Frontier Health

$9.45 /

+0.105 (+1.12%)

 
Syndicate
Willamette Valley Vineyards files $20M mixed securities shelf  17:08
01/24/20
01/24
17:08
01/24/20
17:08
WVVI

Willamette Valley Vineyards

$6.75 /

-0.14 (-2.03%)

 
Hot Stocks
Ashland appoints Dr. Xiaolan Wang to lead Personal Care business unit » 17:04
01/24/20
01/24
17:04
01/24/20
17:04
ASH

Ashland

$75.33 /

-0.66 (-0.87%)

Ashland announced Dr.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
eHealth CEO sells 121K shares of common stock » 16:59
01/24/20
01/24
16:59
01/24/20
16:59
EHTH

eHealth

$123.20 /

+26.11 (+26.89%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Can-Fite BioPharma files to sell $5M of units  16:43
01/24/20
01/24
16:43
01/24/20
16:43
CANF

Can-Fite BioPharma

$2.71 /

+0.02 (+0.74%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
F5 Networks completes acquisition of Shape Security » 16:35
01/24/20
01/24
16:35
01/24/20
16:35
FFIV

F5 Networks

$135.83 /

+1.92 (+1.43%)

F5 Networks announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Preliminary option volume of 30.7M today » 16:30
01/24/20
01/24
16:30
01/24/20
16:30

Preliminary option volume…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
BlueCrest Capital reports 5.1% passive stake in Yatra » 16:25
01/24/20
01/24
16:25
01/24/20
16:25
YTRA

Yatra

$3.50 /

-0.07 (-1.96%)

BlueCrest Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
WiLAN awarded $85.23M in Apple patent infringement retrial » 16:24
01/24/20
01/24
16:24
01/24/20
16:24
AAPL

Apple

$318.25 /

-1.02 (-0.32%)

, QTRH

Quarterhill

$0.00 /

+ (+0.00%)

Wi-LAN, a Quarterhill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Closing CBOE SPX and VIX Index summary for January 24th » 16:20
01/24/20
01/24
16:20
01/24/20
16:20
VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

The CBOE Volatility Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Live Ventures discloses Nasdaq listing deficiency notice » 16:18
01/24/20
01/24
16:18
01/24/20
16:18
LIVE

Live Ventures

$7.70 /

-0.03 (-0.39%)

Live Ventures previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:17
01/24/20
01/24
16:17
01/24/20
16:17
INTC

Intel

$68.47 /

+5.15 (+8.13%)

, DFS

Discover

$76.28 /

-9.49 (-11.06%)

, AXP

American Express

$135.11 /

+3.71 (+2.82%)

, CYOU

Changyou.com

$10.72 /

+0.8 (+8.06%)

, SOHU

Sohu.com

$11.25 /

+ (+0.00%)

, CBB

Cincinnati Bell

$13.78 /

+2.515 (+22.33%)

, BIP

Brookfield Infrastructure

$54.29 /

-0.04 (-0.07%)

, BA

Boeing

$323.04 /

+5.25 (+1.65%)

, EHTH

eHealth

$123.20 /

+26.11 (+26.89%)

, TEAM

Atlassian

$146.77 /

+13.88 (+10.44%)

, SYF

Synchrony

$32.62 /

-3.57 (-9.86%)

, ERIC

Ericsson

$8.32 /

-0.66 (-7.35%)

Stocks closed out a down…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 16:17
01/24/20
01/24
16:17
01/24/20
16:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Tupperware Brands chairman emeritus Rick Goings to retire » 16:16
01/24/20
01/24
16:16
01/24/20
16:16
TUP

Tupperware Brands

$7.77 /

-0.775 (-9.07%)

Tupperware Brands…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Delek Logistics raises quarterly dividend 1% to 88.5c per share » 16:16
01/24/20
01/24
16:16
01/24/20
16:16
DKL

Delek Logistics

$31.81 /

-0.67 (-2.06%)

Delek Logistics Partners,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NYSE market internals summary » 16:16
01/24/20
01/24
16:16
01/24/20
16:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume was average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Yum! Brands raises quarterly dividend to 47c from 42c per share » 16:15
01/24/20
01/24
16:15
01/24/20
16:15
YUM

Yum! Brands

$104.99 /

-0.995 (-0.94%)

The dividend will be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Treasury Market Summary » 16:15
01/24/20
01/24
16:15
01/24/20
16:15

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Bayer Global Investments cuts Crispr Therapeutics stake to 6.1% from 7.2% » 16:14
01/24/20
01/24
16:14
01/24/20
16:14
BAYRY

Bayer

$0.00 /

+ (+0.00%)

, CRSP

Crispr Therapeutics

$54.70 /

-1.82 (-3.22%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FNCB Bancorp raises quarterly dividend to 5.5c from 5c per share » 16:06
01/24/20
01/24
16:06
01/24/20
16:06
FNCB

FNCB Bancorp

$8.03 /

-0.1 (-1.23%)

The dividend is payable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
First Business Financial raises quarterly dividend 10% to 16.5c per share » 16:06
01/24/20
01/24
16:06
01/24/20
16:06
FBIZ

First Business Financial

$26.12 /

+1.02 (+4.06%)

This regular cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Anika Therapeutics completes acquisition of Parcus Medical » 16:06
01/24/20
01/24
16:06
01/24/20
16:06
ANIK

Anika Therapeutics

$43.82 /

-2.22 (-4.82%)

Anika Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Healthcare Merger Corp. to separate trading of Class A stock, warrants » 16:02
01/24/20
01/24
16:02
01/24/20
16:02
HCCO

Healthcare Merger Corp.

$0.00 /

+ (+0.00%)

Healthcare Merger Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Stephens building analysts to hold an analyst/industry conference call » 15:53
01/24/20
01/24
15:53
01/24/20
15:53

Analysts host Kermit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.